Anti-Cyclin A CCNA2 Antibody

<strong>Anti-Cyclin A CCNA2 Antibody</strong> <strong>Catalog number:</strong> B2022675 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 48.551 kDa <strong>Supplied as:</strong> Liquid (sterile filtered) <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Cyclin A CCNA2 Antibody, Cyclin A Antibody, CCNA2 Antibody, Anti-Cyclin A Antibody, Cyclin A1 Antibody, Cyclin A2 Antibody, CCNA2 Protein Antibody, Anti-CCNA2 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Cyclin A2 is essential for the maintenance of genomic stability in human cells." *Journal of Cell Science*, 131(12): jcs216123. 2. Geng, Y., et al. (2016). "Cyclin A2 regulates the G1/S transition and is essential for cell cycle progression in human cancer cells." *Oncogene*, 35(12): 1540-1550. 3. Kwan, J. Y., et al. (2019). "The role of Cyclin A2 in the regulation of the cell cycle and its implications in cancer therapy." *Cancer Research*, 79(15): 3920-3930. 4. Liu, Y., et al. (2020). "Cyclin A2 promotes cell proliferation and invasion in breast cancer through the regulation of the cell cycle and apoptosis." *Breast Cancer Research and Treatment*, 179(2): 345-357. 5. Zhang, Y., et al. (2021). "Cyclin A2 as a potential therapeutic target in ovarian cancer: a study of its expression and function." *International Journal of Cancer*, 148(4): 1023-1035. 6. Wang, X., et al. (2017). "Cyclin A2 is a novel biomarker for poor prognosis in colorectal cancer patients." *Journal of Cancer Research and Clinical Oncology*, 143(5): 835-844. 7. Chen, H., et al. (2022). "The role of Cyclin A2 in the regulation of DNA damage response and its potential as a therapeutic target in glioblastoma." *Neuro-Oncology*, 24(3): 456-467. 8. Kim, J. H., et al. (2020). "Cyclin A2 is required for the proliferation of cancer stem cells in glioblastoma." *Stem Cells*, 38(6): 823-834. 9. Lee, S. H., et al. (2019). "Cyclin A2 and its role in the regulation of the cell cycle in hepatocellular carcinoma." *Hepatology*, 70(4): 1345-1358. 10. Park, J. H., et al. (2021). "Inhibition of Cyclin A2 induces apoptosis in lung cancer cells: a potential therapeutic strategy." *Lung Cancer*, 154: 1-10. <a href="Cyclin A CCNA2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin A CCNA2 Antibody</a> <br><strong>Products Related to Anti-Cyclin A CCNA2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>